IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES

Latest 4/A SEC Filings
Statement of changes in beneficial ownership of securities: [Amend]

EPIGEN INC /DE, 4/A, 2001-01-12
EPIGEN INC /DE, 4/A, 2000-10-06
EPIGEN INC /DE, 4/A, 2000-09-07
EPIGEN INC /DE, 4/A, 2000-08-07
EPIGEN INC /DE, 4/A, 2000-08-03
EPIGEN INC /DE, 4/A, 2000-07-25
MOLECULAR BIOSYSTEMS INC, 4/A, 2000-06-12
ACCUMED INTERNATIONAL INC, 4/A, 1999-09-14
ZYMETX INC, 4/A, 1998-09-11


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission